Ruiqiang Weng

500 total citations
28 papers, 309 citations indexed

About

Ruiqiang Weng is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ruiqiang Weng has authored 28 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Ruiqiang Weng's work include Cancer-related molecular mechanisms research (6 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). Ruiqiang Weng is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). Ruiqiang Weng collaborates with scholars based in China, Taiwan and United States. Ruiqiang Weng's co-authors include Sudong Liu, Xiaodong Gu, Zhixiong Zhong, Pingsen Zhao, Jingyuan Hou, Jing Liu, Yongyu Chen, Wengen Li, Ke Zhang and Chunmei He and has published in prestigious journals such as Scientific Reports, European Journal of Pharmacology and Medicine.

In The Last Decade

Ruiqiang Weng

26 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruiqiang Weng China 10 102 76 74 65 50 28 309
Xiaochuan Xie China 10 85 0.8× 66 0.9× 64 0.9× 41 0.6× 91 1.8× 19 384
Manuela Sebastiano Italy 8 64 0.6× 36 0.5× 41 0.6× 54 0.8× 24 0.5× 9 326
M Konečný Czechia 10 96 0.9× 98 1.3× 84 1.1× 46 0.7× 68 1.4× 46 355
Daniel Marrero–Rodríguez Mexico 12 144 1.4× 75 1.0× 108 1.5× 70 1.1× 44 0.9× 43 404
Ioanna Tiniakou United States 11 92 0.9× 59 0.8× 52 0.7× 37 0.6× 161 3.2× 16 373
Daphna Marom Israel 11 227 2.2× 51 0.7× 113 1.5× 26 0.4× 19 0.4× 26 510
Ranji Hayashi Japan 10 86 0.8× 99 1.3× 58 0.8× 53 0.8× 159 3.2× 24 357
Simone Pasini Italy 8 75 0.7× 74 1.0× 102 1.4× 24 0.4× 103 2.1× 12 394
Eleonora Petito Italy 11 58 0.6× 43 0.6× 36 0.5× 20 0.3× 44 0.9× 25 306
Alexandros Tzovaras Greece 7 78 0.8× 57 0.8× 30 0.4× 36 0.6× 21 0.4× 25 224

Countries citing papers authored by Ruiqiang Weng

Since Specialization
Citations

This map shows the geographic impact of Ruiqiang Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqiang Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqiang Weng more than expected).

Fields of papers citing papers by Ruiqiang Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqiang Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqiang Weng. The network helps show where Ruiqiang Weng may publish in the future.

Co-authorship network of co-authors of Ruiqiang Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqiang Weng. A scholar is included among the top collaborators of Ruiqiang Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqiang Weng. Ruiqiang Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chien‐Ting, et al.. (2025). The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells. Human Vaccines & Immunotherapeutics. 21(1). 2447141–2447141.
2.
3.
Gu, Xiaodong, et al.. (2024). The Diagnosis and Prognosis Value of Circulating Exosomal lncRNA MALAT1 and LNC_000226 in Patients With Acute Myocardial Infarction: An Observational Study. Immunity Inflammation and Disease. 12(12). e70088–e70088. 1 indexed citations
4.
Gu, Xiaodong, Ruiqiang Weng, Qiaoting Deng, et al.. (2024). Interleukin-17D accelerates atherosclerosis through promoting endothelial cells ferroptosis via CD93/miR-181a-5p/SLC7A11 signaling. International Immunopharmacology. 143(Pt 3). 113558–113558. 3 indexed citations
5.
Gu, Xiaodong, et al.. (2024). LncRNA MALAT1 suppresses monocyte-endothelial cell interactions by targeting miR-30b-5p and enhancing ATG5-mediated autophagy. Heliyon. 10(7). e28882–e28882. 4 indexed citations
6.
7.
Tang, Xiaoyan, Ruiqiang Weng, Xueqiang Wu, et al.. (2023). USP10 regulates macrophage inflammation responses via stabilizing NEMO in LPS-induced sepsis. Inflammation Research. 72(8). 1621–1632. 11 indexed citations
8.
Gu, Xiaodong, Ruiqiang Weng, Jingyuan Hou, & Sudong Liu. (2022). Endothelial miR-199a-3p regulating cell adhesion molecules by targeting mTOR signaling during inflammation. European Journal of Pharmacology. 925. 174984–174984. 7 indexed citations
9.
Li, Mingrui, Jingyuan Hou, Xiaodong Gu, et al.. (2022). Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China. European journal of medical research. 27(1). 12–12. 12 indexed citations
10.
Liu, Sudong, Jingyuan Hou, Xiaodong Gu, Ruiqiang Weng, & Zhixiong Zhong. (2021). Characterization of LncRNA expression profile and identification of functional LncRNAs associated with unstable angina. Journal of Clinical Laboratory Analysis. 35(11). e24036–e24036. 6 indexed citations
11.
Liu, Sudong, et al.. (2021). Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case‐control study. Journal of Clinical Laboratory Analysis. 35(12). e24061–e24061. 8 indexed citations
12.
Weng, Ruiqiang, Sudong Liu, Xiaodong Gu, & Zhixiong Zhong. (2021). Clonal diversity of the B cell receptor repertoire in patients with coronary in-stent restenosis and type 2 diabetes. Open Life Sciences. 16(1). 884–898. 3 indexed citations
13.
Weng, Ruiqiang, Sudong Liu, Xiaodong Gu, & Zhixiong Zhong. (2021). Characterization of the B cell receptor repertoire of patients with acute coronary syndrome. Genes & Genomics. 44(1). 19–28. 3 indexed citations
14.
Liu, Boying, et al.. (2020). Elevated serum triglyceride predicts recurrence of colorectal polyps in patients with advanced adenomas. Lipids in Health and Disease. 19(1). 211–211. 13 indexed citations
15.
Liu, Sudong, Xuemin Guo, Wei Zhong, et al.. (2020). Circulating MicroRNA Expression Profiles in Patients with Stable and Unstable Angina. Clinics. 75. e1546–e1546. 5 indexed citations
16.
Liu, Sudong, et al.. (2019). Positivity and prevalence of human papillomavirus among a large population of women in southeastern China. Journal of International Medical Research. 47(12). 6171–6181. 6 indexed citations
17.
Zhao, Pingsen, Sudong Liu, Zhixiong Zhong, et al.. (2018). Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China. BMC Infectious Diseases. 18(1). 204–204. 46 indexed citations
18.
Zhao, Pingsen, Ruiqiang Weng, & Heming Wu. (2018). Molecular Spectrum of α- and β-Thalassemia Mutations in a Large Ethnic Hakka Population in Southern China. Hemoglobin. 42(2). 117–121. 13 indexed citations
19.
Zhao, Pingsen, et al.. (2018). Analysis of expression profiles of long noncoding RNAs and mRNAs in brains of mice infected by rabies virus by RNA sequencing. Scientific Reports. 8(1). 11858–11858. 26 indexed citations
20.
Pan, Lei, et al.. (2014). Immune Response of the VEGF/bFGF Complex Peptide Vaccine and Function of Immune Antibodies in Inhibiting Migration of HUVEC Cells and Proliferation of Cancer Cells. International Journal of Peptide Research and Therapeutics. 20(4). 565–574. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaochuan Xie Breakdown of academic impact, for papers by Manuela Sebastiano Breakdown of academic impact, for papers by M Konečný Breakdown of academic impact, for papers by Daniel Marrero–Rodríguez Breakdown of academic impact, for papers by Ioanna Tiniakou Breakdown of academic impact, for papers by Daphna Marom Breakdown of academic impact, for papers by Ranji Hayashi Breakdown of academic impact, for papers by Simone Pasini Breakdown of academic impact, for papers by Eleonora Petito Breakdown of academic impact, for papers by Alexandros Tzovaras
Rankless by CCL
2026